BOIRF (Boiron) Moat Score: 0/10 (As of Jun. 29, 2026)


BOIRF Boiron SA BOIRF
62 GF Score
Price $31.90
GF Value $38.49
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Boiron Moat Score?

Boiron has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Boiron has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Boiron might have No Moat - No discernible moat.

Boiron  (OTCPK:BOIRF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Boiron Moat Score Related Terms

BOIRF
62GF Score
Boiron SA BOIRF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Boiron (BOIRF) Overvalued in 2026?

Based on GuruFocus' analysis, Boiron stock appears to be undervalued. The current stock price of $31.90 is trading 17.1% below its estimated GF Value™ of $38.49. GuruFocus considers Boiron to be Modestly Undervalued.

Key valuation signals for BOIRF:

  • Moat Score: 0
  • GF Value™: $38.49 vs. price of $31.90 (17.1% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the BOIRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boiron Business Description

Address 2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
62GF Score

Get the complete analysis for BOIRF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.90
Price
$38.49
GF Value